Cite

HARVARD Citation

    Colombo, G. et al. (2019). Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review. Therapeutic advances in respiratory disease. p. . [Online]. 
  
Back to record